Jim Simons’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.91M Buy
607,515
+172,000
+39% +$1.58M 0.01% 1279
2025
Q4
$4.16M Buy
435,515
+64,215
+17% +$654K 0.01% 1406
2025
Q3
$3.62M Buy
371,300
+281,100
+312% +$2.16M ﹤0.01% 1673
2025
Q2
$548K Sell
90,200
-149,700
-62% -$1.12M ﹤0.01% 2788
2025
Q1
$2.97M Buy
239,900
+38,000
+19% +$537K ﹤0.01% 1752
2024
Q4
$2.8M Buy
201,900
+19,100
+10% +$301K ﹤0.01% 1832
2024
Q3
$3.06M Sell
182,800
-146,700
-45% -$3.15M ﹤0.01% 1749
2024
Q2
$6.8M Sell
329,500
-60,200
-15% -$1.3M 0.01% 1125
2024
Q1
$9.65M Buy
389,700
+53,900
+16% +$1.6M 0.02% 1006
2023
Q4
$12.2M Buy
335,800
+75,200
+29% +$2.89M 0.02% 849
2023
Q3
$12.6M Sell
260,600
-63,200
-20% -$3.75M 0.02% 790
2023
Q2
$22.1M Sell
323,800
-83,500
-21% -$5.39M 0.03% 632
2023
Q1
$19.7M Sell
407,300
-67,600
-14% -$3.57M 0.03% 722
2022
Q4
$28.6M Sell
474,900
-162,000
-25% -$9.49M 0.04% 552
2022
Q3
$38.6M Sell
636,900
-49,100
-7% -$1.55M 0.05% 405
2022
Q2
$18.6M Buy
686,000
+291,800
+74% +$8.54M 0.02% 772
2022
Q1
$14.4M Buy
394,200
+127,400
+48% +$4.59M 0.02% 923
2021
Q4
$13.2M Buy
266,800
+9,600
+4% +$532K 0.02% 936
2021
Q3
$18.3M Buy
257,200
+18,900
+8% +$1.17M 0.02% 716
2021
Q2
$12.3M Sell
238,300
-50,700
-18% -$1.58M 0.02% 1036
2021
Q1
$7.26M Sell
289,000
-25,000
-8% -$470K 0.01% 1407
2020
Q4
$3.77M Buy
314,000
+48,800
+18% +$577K ﹤0.01% 1762
2020
Q3
$2.65M Sell
265,200
-122,762
-32% -$1.48M ﹤0.01% 1960
2020
Q2
$4.06M Buy
387,962
+303,062
+357% +$3.37M ﹤0.01% 1772
2020
Q1
$908K Buy
84,900
+15,800
+23% +$191K ﹤0.01% 2476
2019
Q4
$1.09M Buy
69,100
+24,100
+54% +$258K ﹤0.01% 2586
2019
Q3
$353K Buy
+45,000
New +$400K ﹤0.01% 2987
2019
Q2
Sell
-12,800
Closed -$155K 3718
2019
Q1
$155K Buy
+12,800
New +$160K ﹤0.01% 3243
2018
Q4
Sell
-57,400
Closed -$751K 3558
2018
Q3
$751K Buy
+57,400
New +$829K ﹤0.01% 2726
2018
Q1
Sell
-42,700
Closed -$1.6M 3528
2017
Q4
$1.6M Buy
+42,700
New +$2.17M ﹤0.01% 2464
2016
Q1
Sell
-90,600
Closed -$6.17M 3499
2015
Q4
$6.17M Buy
90,600
+54,200
+149% +$3.27M 0.01% 1329
2015
Q3
$1.65M Buy
+36,400
New +$2.12M ﹤0.01% 2110
2014
Q4
Sell
-17,300
Closed -$383K 3084
2014
Q3
$383K Sell
17,300
-34,600
-67% -$734K ﹤0.01% 2400
2014
Q2
$1.17M Sell
51,900
-27,212
-34% -$680K ﹤0.01% 1983
2014
Q1
$3.03M Buy
79,112
+14,512
+22% +$468K 0.01% 1548
2013
Q4
$1.71M Buy
+64,600
New +$1.62M ﹤0.01% 1832

Other funds holding PRTA

Jim Simons's PRTA Position: Q1 2026 in Review

Jim Simons increased its Prothena Corp (PRTA) stake by 39% in Q1 2026, buying an estimated $1.58M and bringing the position to 607,515 shares worth $5.91M. The position accounts for 0.01% of the portfolio, ranked #1279.

Jim Simons first reported a position in PRTA in Q4 2013 and has held it in 36 quarters since. The position peaked at $38.6M in Q3 2022. 185 funds tracked by Wall St. Rank hold PRTA as of Q1 2026.

  • Jim Simons held 607,515 shares of Prothena Corp worth $5.91M as of Q1 2026.
  • Jim Simons bought 172,000 Prothena Corp shares in Q1 2026, an estimated $1.58M.
  • Prothena Corp made up 0.01% of Jim Simons's portfolio in Q1 2026, its #1279 holding.
  • Jim Simons first reported a position in Prothena Corp in Q4 2013 and has held it in 36 quarters since.
  • Jim Simons's Prothena Corp position peaked at $38.6M in Q3 2022.
  • 185 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.